Of the remaining 1474 patients, the mean age was 58.8 ± 12.9 years and the most common tumor biology was HR+/Her2− (76.1%), followed by Her2+ (14.7%) and triple negative (9.2%). This evidence concerns the gene ERBB2 and neoplasm.